Podcast
Questions and Answers
What is the advantage of acellular pertussis vaccines compared to whole-cell vaccines?
What is the advantage of acellular pertussis vaccines compared to whole-cell vaccines?
What type of vaccine was the first licensed for immunization of infants in 1990?
What type of vaccine was the first licensed for immunization of infants in 1990?
What is the role of the polysaccharide capsule in conjugate polysaccharide vaccines?
What is the role of the polysaccharide capsule in conjugate polysaccharide vaccines?
Why do polysaccharides not produce effective immunity in infants?
Why do polysaccharides not produce effective immunity in infants?
Signup and view all the answers
What modification is made to the pertussis toxin vaccine to render it non-toxic?
What modification is made to the pertussis toxin vaccine to render it non-toxic?
Signup and view all the answers
What percentage of deaths due to infectious diseases occurs in developing countries?
What percentage of deaths due to infectious diseases occurs in developing countries?
Signup and view all the answers
Why are vaccines considered an important tool in developing countries?
Why are vaccines considered an important tool in developing countries?
Signup and view all the answers
What type of traditional vaccine involves attenuated viral or bacterial strains?
What type of traditional vaccine involves attenuated viral or bacterial strains?
Signup and view all the answers
What is a potential risk of using live vaccines?
What is a potential risk of using live vaccines?
Signup and view all the answers
Which of the following is a characteristic of killed vaccines?
Which of the following is a characteristic of killed vaccines?
Signup and view all the answers
Why is vaccination important in veterinary medicine?
Why is vaccination important in veterinary medicine?
Signup and view all the answers
Which of the following is a concern with traditional vaccines?
Which of the following is a concern with traditional vaccines?
Signup and view all the answers
What challenge is commonly faced in the production of killed vaccines?
What challenge is commonly faced in the production of killed vaccines?
Signup and view all the answers
What is a protective antigen?
What is a protective antigen?
Signup and view all the answers
Which of the following are characteristics of recombinant DNA technology in vaccine production?
Which of the following are characteristics of recombinant DNA technology in vaccine production?
Signup and view all the answers
What is one key disadvantage of the acellular pertussis vaccine?
What is one key disadvantage of the acellular pertussis vaccine?
Signup and view all the answers
What led to the development of acellular vaccines in Japan and Sweden?
What led to the development of acellular vaccines in Japan and Sweden?
Signup and view all the answers
Which statement about subunit vaccines is true?
Which statement about subunit vaccines is true?
Signup and view all the answers
What was the annual incidence of pertussis cases in the United States before vaccination?
What was the annual incidence of pertussis cases in the United States before vaccination?
Signup and view all the answers
Which component is typically included in the acellular pertussis vaccine?
Which component is typically included in the acellular pertussis vaccine?
Signup and view all the answers
What type of organism is often used to produce antigens for vaccines safely?
What type of organism is often used to produce antigens for vaccines safely?
Signup and view all the answers
Study Notes
Recombinant and Synthetic Vaccines
- Infectious diseases cause 30% to 50% of deaths in developing countries.
- Effective chemotherapeutic agents are often unavailable or too expensive.
- Vaccines are crucial in combating infectious diseases in developing nations.
- Developed countries experience a lower rate of infectious disease mortality (4%-8%).
Widespread Use of Vaccination
- Smallpox vaccination
- Diphtheria (caused by Corynebacterium diphtheriae)
- Poliomyelitis vaccination
Cost-Efficiency
- Vaccination is less expensive than treating existing illnesses.
- Vaccines remain vital in veterinary medicine.
- Farm animals in close proximity increase cross-infection rates.
Recombinant and Synthetic Vaccines - Table 5.1
- Attenuated live pathogens: Measles, Mumps, Rubella (German measles), Varicella (chickenpox) use attenuated live viruses.
- Inactivated whole pathogens: Poliomyelitis uses inactivated viruses.
- Modified components of pathogens: Diphtheria and Tetanus use toxoids, Pertussis uses components of the pathogen.
- Recombinant DNA derived subunit vaccine: Hepatitis B uses surface antigens produced in yeast cells.
Recombinant and Synthetic Vaccines - Chronology
- Smallpox, 1800
- Rabies, 1900
- Mention of additional diseases: Hepatitis B, Pneumococcus, Meningococcus, Rubella, Mumps, Measles, Polio (Sabin and Salk), Yellow fever, Influenza, Pertussis, Cholera, Tetanus, Tuberculosis, Diphtheria, and Typhoid.
Problems with Traditional Vaccines
- Traditional vaccines are live or killed.
- Live vaccines contain weakened viral or bacterial strains; prolonged storage or suboptimal conditions.
- Killed vaccines contain killed whole cells or inactivated toxin proteins (toxoids).
- Many traditional vaccines are effective but new vaccines and techniques are often necessary.
- Vaccines for various diseases are not yet developed, or those developed are not sufficiently effective or safe.
Problems with Traditional Vaccines - (Table 5.2)
- Shows examples of diseases with no/limited effective vaccines: AIDS, Diarrhea, Tuberculosis, Malaria, Hepatitis C, Leishmaniasis, Trypanosomiasis, Schistosomiasis, and Chagas disease.
- Mentions data sources.
Problems with Traditional Vaccines - Graph
- Shows the incidence of poliomyelitis cases and vaccine-associated paralytic poliomyelitis (VAPP) in the United States from 1960 to 1996.
Problems with Traditional Vaccines - Continued
- Danger of reversion to virulent state.
- Need for tissue culture cell growth – possible hidden viruses.
- Potential for adverse reactions from vaccines themselves.
- "Whole-cell" vaccine for pertussis may cause adverse effects.
- Potential risks to workers involved in vaccine production.
- Potential issues with complete killing/inactivation rates.
- Difficulty with sufficient vaccine quantities.
Impact of Biotechnology on Vaccine Development
- Biotechnology advancements lead to new vaccine types.
- Targeting specific new pathogen targets.
- Improved vaccine efficacy/safety.
- Protective antigens—molecules generating immunity.
- Use of recombinant DNA methods for vaccine production.
- Utilizing non-pathogenic organisms.
Impact of Biotechnology on Vaccine Development - Continued
- Recombinant DNA enables vaccine production even when pathogens are hard/impossible to cultivate.
- New vaccines often target one/few molecules.
- Subunit vaccines: new vaccines contain one or some of the original pathogen molecules.
- Acellular pertussis vaccine, conjugate polysaccharide vaccines - developed using non-recombinant DNA methods.
- Hepatitis B subunit vaccine using recombinant DNA techniques.
Acellular Pertussis Vaccine
- Pertussis/whooping cough is a significant childhood disease.
- Before vaccines, it resulted in illness and high death rates in the US.
- WHO reports significantly higher rates globally.
- Traditional whole-cell vaccine reduced cases but caused significant safety concerns (infant death, decreased efficacy), leading to the development of acellular vaccines.
- Acellular vaccines use purified pertussis toxin (inactivated), and other components.
- Acellular vaccines are generally more effective and safe than the older whole cell vaccine.
- Chiron now produces a recombinant DNA-derived pertussis toxin vaccine in Europe. The toxic activity is inactivated without altering the protein structure.
Conjugate Polysaccharide Vaccines
- Effective vaccines for invasive Haemophilus influenzae type b(Hib) and Streptococcus pneumoniae cases.
- Protective antigen in these vaccines is the polysaccharide capsule.
- Polysaccharides provide immunity in adults, but not necessarily infants.
- Conjugation to a carrier protein is necessary to generate adequate immunity in infants.
Conjugate H. Influenzae Vaccines
- First licensed conjugate Hib vaccines in 1990.
- Pneumococcal conjugate vaccines in 2000.
- Improved versions reduce cases and are crucial in reducing disease.
Other Information
- Mention of CRM197, a diphtheria toxin variant, used in some conjugate vaccines.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz covers the critical role of recombinant and synthetic vaccines in combating infectious diseases, particularly in developing nations. It discusses the cost-efficiency of vaccination and highlights key vaccinations such as those for smallpox and poliomyelitis. Understand how different types of vaccines, including attenuated and inactivated pathogens, play a significant role in both human and veterinary medicine.
